| Symbol |
Name |
|
ACTG1
|
actin gamma 1
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
|
ATP1A3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide
|
|
ATP1A4
|
ATPase, Na+/K+ transporting, alpha 4 polypeptide
|
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide
|
|
ATP1B2
|
ATPase, Na+/K+ transporting, beta 2 polypeptide
|
|
ATP1B3
|
ATPase, Na+/K+ transporting, beta 3 polypeptide
|
|
ATP1B4
|
ATPase, Na+/K+ transporting, beta 4 polypeptide
|
|
ATP2A1
|
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1
|
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
|
ATP2A3
|
ATPase, Ca++ transporting, ubiquitous
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BMP4
|
bone morphogenetic protein 4
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CCND1
|
cyclin D1
|
|
CLSTN1
|
calsyntenin 1
|
|
CREBBP
|
CREB binding protein
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
DIDO1
|
death inducer-obliterator 1
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
DIO3
|
deiodinase, iodothyronine, type III
|
|
EP300
|
E1A binding protein p300
|
|
ESR1
|
estrogen receptor 1
|
|
FOXO1
|
forkhead box O1
|
|
FXYD2
|
FXYD domain containing ion transport regulator 2
|
|
GATA4
|
GATA binding protein 4
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC3
|
histone deacetylase 3
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
KAT2A
|
K(lysine) acetyltransferase 2A
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
LNCEGFL7OS
|
lncRNA EGFL7 opposite strand
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MBD4
|
methyl-CpG binding domain protein 4
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MED12
|
mediator complex subunit 12
|
|
MED12L
|
mediator complex subunit 12-like
|
|
MED13
|
mediator complex subunit 13
|
|
MED13L
|
mediator complex subunit 13-like
|
|
MED14
|
mediator complex subunit 14
|
|
MED16
|
mediator complex subunit 16
|
|
MED17
|
mediator complex subunit 17
|
|
MED24
|
mediator complex subunit 24
|
|
MED27
|
mediator complex subunit 27
|
|
MED30
|
mediator complex subunit 30
|
|
MED4
|
mediator complex subunit 4
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYH6
|
myosin, heavy chain 6, cardiac muscle, alpha
|
|
MYH7
|
myosin, heavy chain 7, cardiac muscle, beta
|
|
NCOA1
|
nuclear receptor coactivator 1
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NOTCH3
|
notch 3
|
|
NOTCH4
|
notch 4
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PFKFB2
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2
|
|
PFKL
|
phosphofructokinase, liver
|
|
PFKM
|
phosphofructokinase, muscle
|
|
PFKP
|
phosphofructokinase, platelet
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIK3R2
|
phosphoinositide-3-kinase, regulatory subunit 2 (beta)
|
|
PIK3R3
|
phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
|
|
PLCB1
|
phospholipase C, beta 1 (phosphoinositide-specific)
|
|
PLCB2
|
phospholipase C, beta 2
|
|
PLCB3
|
phospholipase C, beta 3 (phosphatidylinositol-specific)
|
|
PLCB4
|
phospholipase C, beta 4
|
|
PLCD1
|
phospholipase C, delta 1
|
|
PLCD3
|
phospholipase C, delta 3
|
|
PLCD4
|
phospholipase C, delta 4
|
|
PLCE1
|
phospholipase C, epsilon 1
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
|
PLCZ1
|
phospholipase C, zeta 1
|
|
PLN
|
phospholamban
|
|
POTEF
|
POTE ankyrin domain family, member F
|
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
|
PRKACG
|
protein kinase, cAMP-dependent, catalytic, gamma
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCG
|
protein kinase C, gamma
|
|
RCAN1
|
regulator of calcineurin 1
|
|
RCAN2
|
regulator of calcineurin 2
|
|
RHEB
|
Ras homolog enriched in brain
|
|
RNASE3
|
ribonuclease, RNase A family, 3
|
|
RXRA
|
retinoid X receptor, alpha
|
|
RXRB
|
retinoid X receptor, beta
|
|
RXRG
|
retinoid X receptor, gamma
|
|
SIN3A
|
SIN3 transcription regulator family member A
|
|
SLC16A10
|
solute carrier family 16 (aromatic amino acid transporter), member 10
|
|
SLC16A2
|
solute carrier family 16, member 2 (thyroid hormone transporter)
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SLCO1C1
|
solute carrier organic anion transporter family, member 1C1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
TBC1D4
|
TBC1 domain family, member 4
|
|
THRA
|
thyroid hormone receptor, alpha
|
|
THRB
|
thyroid hormone receptor, beta
|
|
TP53
|
tumor protein p53
|
|
TSC2
|
tuberous sclerosis 2
|
|
WNT4
|
wingless-type MMTV integration site family, member 4
|
